暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
CPHI 惠普森医药
- 0.3023
- -0.0237-7.27%
收盘价 04/26 16:00 (美东)
447.91万总市值-332市盈率TTM
0.3249最高价0.3023最低价23.31万股成交量0.3085今开0.3260昨收7.22万成交额4.16%换手率亏损市盈率(静)1481.69万总股本2.176552周最高0.60市净率169.38万流通值0.271052周最低--股息TTM560.30万流通股2044.2703历史最高--股息率TTM6.93%振幅0.2710历史最低0.3090平均价1股每手
盘前分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
周一盘前交易时段，12只医疗保健股走势
在周一的盘前交易中，GainersGalera Therapeutics（纳斯达克股票代码：GRTX）股价上涨了62.8％，至0.23美元。他们已发行股票的市值为1,230万美元。根据新闻，t
周二盘后交易时段，12只医疗保健股走势
在周二的盘后交易中，GainersLexaria Bioscience（纳斯达克股票代码：LEXX）股价上涨10.0％，至2.64美元。他们已发行股票的市值为3,220万美元。中国医药控股 (AMEX: C
中国医药控股宣布反向股票拆分
惠普森医药将于2024年3月6日除权除息，5股合为1股
2月24日消息，$惠普森医药(CPHI.US)$将于2024年3月6日除权除息，5股合为1股。截至2月23日收盘，$惠普森医药(CPHI.US)$报0.088美元，跌2.65%，当日成交额15.3万美元，总市值483.72万美元。什么是合股？ 合股是拆股的相反过程，当股票价格较低时，为了提升公司形象，上市公司会将已发行的股票按比例进行合并，即由多股合并为1股。合股后，股价按照相应比例提高，股东权益
周五盘后交易时段，12只医疗保健类股走势
在周五的盘后交易中，GainersOcean Biomedical（纳斯达克股票代码：OCEA）股价上涨37.6％，至2.16美元。该公司的市值为7,360万美元。NeuBase Therapeutics（纳斯达克股票代码：NBSE）股价上涨
快讯 | 中国医药控股宣布以1比5的比例进行反向股票拆分
评论
$惠普森医药(CPHI.US$ Buy the dip...Upwards coming soon
$惠普森医药(CPHI.US$ Buy the dip...Upwards coming soon
$China Pharma (CPHI.US)$ Launch date is coming Up. Maxrale
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
1
Launch date is coming Up. Maxrale
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
$惠普森医药(CPHI.US$ Ready to move. tiny float
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅